BioCentury
ARTICLE | Company News

BioMimetix, Duke University deal

July 25, 2011 7:00 AM UTC

The university granted newco BioMimetix an exclusive license to develop a class of patented compounds to treat radiation toxicity incurred during the treatment of cancer. Terms were not disclosed. ...